Form D · Other

Orpyx Medical Technologies Inc.

Calgary, A0 · CIK 0001734500

Offering snapshot reported Oct 24, 2023 · SEC filing

Reported sold
$11K
Offering amount: $11K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 10, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 24, 2023Initial$11,000No comparison1SEC filing
Jul 21, 2020Amendment$407,909$57,909vs Jun 19, 20202SEC filing
Jun 19, 2020Initial$350,000No comparison1SEC filing
Mar 16, 2018Initial$6,304No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-495535

Source: Form D, filed Oct 24, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Barry Allen Director
Robert Bray Director
Denis Brisson Executive
Peter Calverley Director
Breanne Everett Director, Executive
Jeffrey Helper Executive
David Mc Faul Director
Cory Paddock Director
Travis Stevens Executive
David Taylor Director
Lew Turnquist Director, Executive
Sharilyn Dawne Weisbeck Executive

Issuer details

Industry: Other (See others in industry)

Address:
1240 20th Ave. S.E. Ste 205
Calgary, A0, T2G 1M8